PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsFoster
Foster
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
726 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
ObesityD009765EFO_0001073E66.9—2—12124
AsthmaD001249EFO_0000270J45—665320
Chronic obstructive pulmonary diseaseD029424EFO_0000341J44.9—161311
Adolescent behaviorD000294—————1910
Lung diseasesD008171EFO_0003818J98.4——6118
Obstructive lung diseasesD008173————5128
OverweightD050177—E66.3—1—135
Tennis elbowD013716EFO_1001896M77.1———1—1
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Mental disordersD001523EFO_0000677F91.9—11—2728
Problem behaviorD000066553——322—1217
Pediatric obesityD063766———11—1314
NeoplasmsD009369—C80112—1114
Child developmentD002657———11—1213
Mental healthD008603EFO_0003935——11—1112
Prostatic neoplasmsD011471—C61—11—68
Hiv infectionsD015658EFO_0000764B20—11—67
Child behavior disordersD002653———11—45
SmokingD012907EFO_0004318—111—35
Show 5 more
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
DepressionD003863—F33.941——5257
Depressive disorderD003866EFO_1002014F32.A21——2124
Substance-related disordersD019966EFO_0003890F13—1——2223
SchizophreniaD012559EFO_0000692F2021——1619
Diabetes mellitusD003920EFO_0000400E08-E13—1——1314
StrokeD020521EFO_0000712I63.9—1——1213
ExerciseD015444EFO_0000483——1——1213
Psychological distressD000079225———1——1011
HivD006678—O98.7—1——910
Smoking cessationD016540EFO_0004319—32——710
Show 42 more
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Psychotic disordersD011618—F20.812———1719
Post-traumatic stress disordersD013313EFO_0001358F43.11———1617
Healthy volunteers/patients———1———1011
SuicideD013405——1———78
Major depressive disorderD003865EFO_0003761F221———67
Brain injuriesD001930—S06.91———56
Attention deficit disorder with hyperactivityD001289EFO_0003888F901———56
Schizophrenia spectrum and other psychotic disordersD019967——1————1
Carpal tunnel syndromeD002349EFO_0004143G56.01————1
GalactosemiasD005693—E74.211————1
Show 3 more
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
AnxietyD001007EFO_0005230F41.1————1919
Psychological stressD013315——————1313
ParentingD016487——————1313
DementiaD003704EFO_0003862F03————1313
Health behaviorD015438——————1313
Anxiety disordersD001008EFO_0006788F41.1————1212
Traumatic stress disordersD040921——————1111
Parent-child relationsD010287——————1111
Cognitive dysfunctionD060825—G31.84————1010
Breast neoplasmsD001943EFO_0003869C50————1010
Show 426 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common name—
INN—
Description
—
Classification
Unknown
Drug class—
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)—
Identifiers
PDB—
CAS-ID—
RxCUI—
ChEMBL ID—
ChEBI ID—
PubChem CID—
DrugBank—
UNII ID—
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
190 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use